Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 7;19(1):6.
doi: 10.1007/s12105-024-01745-z.

The Patterns of P53, E-Cadherin, β-Catenin, CXCR4 and Podoplanin Expression in Oral Squamous Cell Carcinoma Suggests a Hybrid Invasion Model: an Immunohistochemical Study on Tissue Microarrays

Affiliations

The Patterns of P53, E-Cadherin, β-Catenin, CXCR4 and Podoplanin Expression in Oral Squamous Cell Carcinoma Suggests a Hybrid Invasion Model: an Immunohistochemical Study on Tissue Microarrays

Daniele Heguedusch et al. Head Neck Pathol. .

Abstract

Purpose: Oral squamous cell carcinoma (OSCC) is a significant public health challenge associated with high mortality rates primarily due to its invasive and metastatic behavior. This study aimed to evaluate the expression patterns of five critical biomarkers: β-catenin, E-cadherin, podoplanin (PDPN), CXCR4, and p53 in OSCC tissues and to investigate their correlations with clinicopathologic features and patient outcomes.

Methods: We conducted an immunohistochemical analysis utilizing tissue microarrays (TMAs) from 95 patients diagnosed with primary OSCC. The expression levels of the five biomarkers were quantified using H-scores. Statistical analyses, including Kruskal-Wallis tests, Dunn's post-hoc tests, and correlation analyses, were performed to explore the associations between biomarker expression, clinicopathologic parameters, and overall patient survival.

Results: The study found that loss of E-cadherin and β-catenin expression was significantly associated with increased tumor depth and lymphatic invasion, corroborating their role in the process of epithelial-mesenchymal transition (EMT). High levels of PDPN were noted in both early and late-stage OSCC, indicating its potential involvement in initiating invasive behaviors. Notably, CXCR4 expression exhibited positive correlations with E-cadherin and β-catenin, suggesting a hybrid invasion phenotype incorporating both EMT and collective invasion strategies. Although Cox regression analysis did not reveal significant associations between biomarker expression and overall survival (OS) or disease-specific survival (DSS), factors such as alcohol consumption, tumor size, lymph node involvement, and advanced clinical stage emerged as significant negative predictors of both OS and DSS.

Conclusion: The expression profiles of β-catenin, E-cadherin, PDPN, CXCR4, and p53 in OSCC tissues provide valuable insights into a hybrid model of invasion that integrates mechanisms of EMT with an important rule in the tumor invasion. This nuanced understanding of OSCC progression highlights the potential of PDPN and CXCR4 as novel therapeutic targets, emphasizing the need for further investigation into their roles in OSCC biology and the development of targeted treatments that could improve patient outcomes and survival rates.

Keywords: Epithelial-mesenchymal transition; Oral squamous cell carcinoma; Tissue microarray.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing Interests: The authors declare no competing interests.

Similar articles

References

    1. Bray F et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229–263. 10.3322/caac.21834 - PubMed
    1. Instituto Nacional De Câncer (2023) Estimativa 2023: incidência de câncer no Brasil. Rio de Janeiro. Accessed 03 Nov 2024. https://www.inca.gov.br/publicacoes/livros/estimativa-2023-incidencia-de...
    1. Gharat SA, Momin M, Bhavsar C (2016) Oral squamous cell carcinoma: current treatment strategies and nanotechnology-based approaches for Prevention and Therapy. Crit Rev Ther Drug Carrier Syst 33(4):363–400. 10.1615/CritRevTherDrugCarrierSyst.2016016272 - PubMed
    1. Gigliotti J, Madathil S, Makhoul N (Sep. 2019) Delays in oral cavity cancer. Int J Oral Maxillofac Surg 48(9):1131–1137. 10.1016/j.ijom.2019.02.015 - PubMed
    1. Kowalski LP, de Oliveira MM, Lopez RVM, Silva DRME, Ikeda MK, Curado MP (2020) Survival trends of patients with oral and oropharyngeal cancer treated at a cancer center in São Paulo, Brazil. Clin Sao Paulo Braz 75:e1507. 10.6061/clinics/2020/e1507 - PMC - PubMed

MeSH terms

LinkOut - more resources